As the spring season begins to bloom, an exciting opportunity awaits oncology clinical trial professionals. The Society of Clinical Research Associates (SOCRA) is hosting its annual Oncology Clinical Trials Conference in the vibrant city of Nashville, TN, this March. Set for March 27-28, 2025, with preconference workshops on March 26, this event is a pivotal gathering for those involved in oncology research. This year’s conference will continue to serve as an essential platform for learning, networking, and professional growth.
Co-chaired by Tammy Neseth, MA, CCRP, CIP, and Susanna Sellmann, RTT, BS, CCRP, this conference has grown into one of the most influential events for clinical trial professionals in the oncology field. As part of our ongoing commitment to advancing oncology clinical research, this year’s event will provide updated knowledge, regulatory insights, and hands-on experiences designed to equip attendees with the tools needed to navigate the complexities of oncology trials.
A Growing Legacy: What to Expect This Year
Since its inception in 2015, the Oncology Clinical Trials Conference has been tailored to meet the unique challenges of oncology research. Attendees can expect an updated program that reflects the evolving landscape of clinical trials in oncology. The introduction of preconference workshops will continue to play a key role in this conference, offering deep dives into the basics of Good Clinical Practice (GCP) and Oncology Research Fundamentals, both of which are crucial for those newer to the field or looking to refine their knowledge.
- GCP E6 (R2) Basics Preconference Workshop: This workshop focuses on the fundamental standards required for designing, conducting, recording, and reporting oncology clinical trials. It meets NIH requirements for GCP training and is perfect for those seeking to solidify their understanding of clinical trial quality standards.
- Oncology Research Fundamentals Preconference Workshop: This session will provide a comprehensive overview of oncology research, including cancer statistics, terminology, cancer diagnosis, staging, and grading. It also offers a deeper look into Response Evaluation Criteria in Solid Tumors (RECIST), a critical component of oncology trials.
Networking and Career Development
One of the standout features of this conference is its emphasis on networking. As the oncology clinical trials field continues to expand and evolve, making connections with peers, experts, and potential collaborators is more important than ever. Whether you’re a seasoned professional or new to the field, the conference provides countless opportunities to connect with others who share your passion and commitment.
This year, attendees will benefit from an even more diverse set of networking opportunities, including icebreaker games, social events, and small-group discussions that foster collaboration and idea-sharing. Attendees can engage in meaningful conversations, expand their professional networks, and find inspiration for their ongoing work in oncology clinical trials.
New and Updated Sessions
This year’s agenda boasts a range of dynamic sessions led by industry leaders and experts. Some of the key topics will include:
- Immunotherapy in Oncology: With immunotherapy becoming an increasingly important treatment option, sessions will delve into how this emerging class of cancer treatment works and the unique challenges involved in its clinical trials.
- Pharmacokinetics and Pharmacodynamics: Jeff Doi’s session on pharmacokinetics, pharmacodynamics, and drug interactions will provide attendees with a deeper understanding of these essential concepts in oncology research.
- Regulatory Considerations: Erin Lynch will discuss the regulatory landscape for oncology clinical trials, helping attendees navigate the complex regulatory environment and stay up to date with the latest requirements.
- Imaging in Oncology Trials: Dr. Stuart Bentley-Hibbert’s session on imaging techniques used in clinical trials will offer practical insights into the critical role of imaging in evaluating treatment outcomes.
New for this year is the focus on quality specimen management, led by Vanessa Speers, which will explore the importance of this often-overlooked area in oncology research.
Poster Program: Share Your Work
As in previous years, the poster program will allow participants to showcase their research, findings, and best practices in oncology clinical trials. This is an excellent opportunity for professionals to present their work, gain valuable feedback, and engage with colleagues who share similar interests in clinical research. Submitting a poster abstract allows you to contribute to advancing the field while enhancing your professional profile.
Why You Should Attend
With its rich blend of educational sessions, networking opportunities, and hands-on workshops, the Oncology Clinical Trials Conference is an event that no clinical research professional should miss. Whether you’re new to oncology trials or an experienced coordinator, this conference offers something for everyone.
By attending, you’ll gain essential insights into current trends, regulatory challenges, and emerging treatments in oncology research. You’ll also have the chance to interact with experts, contribute to the oncology research community, and walk away feeling inspired to apply your new knowledge in your daily work.
For more information, including registration details, the poster program, and hotel reservations, visit the SOCRA website or call the conference team at 423.424.2814. Be sure to book your room at the DoubleTree by Hilton Nashville Downtown by February 25, 2025, to secure the SOCRA hotel rate of $269 per night.
We look forward to welcoming you to Nashville, TN, for an event that is set to shape the future of oncology clinical trials. Don’t miss out on this exciting opportunity to enhance your expertise and connect with fellow professionals who are passionate about advancing cancer research.